{"id":"W1965294429","doi":"10.2174/187152607780090748","title":"Exploring DNA Topoisomerases as Targets of Novel Therapeutic Agents in the Treatment of Infectious Diseases","year":2007,"lang":"en","type":"review","venue":"Infectious Disorders - Drug Targets","topic":"Cancer therapeutics and mechanisms","field":"Biochemistry, Genetics and Molecular Biology","cited_by":82,"is_retracted":false,"has_abstract":true,"ca_institutions":"","funders":"National Institute of Neurological Disorders and Stroke; Public Health Agency; National Institute of General Medical Sciences; National Institute of Allergy and Infectious Diseases; Institut pour la Recherche en Santé Publique; Natural Sciences and Engineering Research Council of Canada; Canadian Institutes of Health Research","keywords":"Topoisomerase; DNA gyrase; Topoisomerase IV; Topoisomerase inhibitor; Biology; DNA; DNA supercoil; Gene; Biochemistry; DNA replication; Escherichia coli","routes":{"ca_aff":false,"ca_fund":true,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":true},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005856371,0.0004255603,0.0005837804,0.000851029,0.0002184421,0.001035786,0.0005021601,0.0007327002,0.002636608],"category_scores_gemma":[0.0003696832,0.0002108816,0.0005787031,0.0004045741,0.0003237197,0.0008967547,0.0004575496,0.001306246,0.0007835601],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0005186578,"about_ca_system_score_gemma":0.0005869407,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0003294553,"about_ca_topic_score_gemma":0.0008803722,"domain_scores_codex":[0.9997726,0.00005146456,0.00001227591,0.00003606764,0.00007814787,0.00004939387],"domain_scores_gemma":[0.9998738,0.00002841355,0.00002500979,0.000006312065,0.00003854687,0.00002797829],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.001168792,0.001017979,0.003190262,0.008231327,0.0002977055,0.001405319,0.0004745331,0.003376492,0.3749581,0.01882285,0.01603522,0.5710215],"study_design_scores_gemma":[0.0004754965,0.006396445,0.00749427,0.001823549,0.0006231182,0.003267281,0.0005005747,0.00525033,0.1489607,0.01267282,0.812436,0.00009928905],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.06092519,0.9041131,0.01096412,0.005419953,0.00101862,0.0002079484,0.0003544599,0.0001722885,0.01682438],"genre_scores_gemma":[0.266339,0.7074726,0.01173634,0.002505027,0.001073148,0.0002224691,0.0005872135,0.00003917787,0.01002504],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.002636608,"threshold_uncertainty_score":0.008820355,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.07881365482780489,"score_gpt":0.3410781888377091,"score_spread":0.2622645340099042,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}